Laboratory Diagnosis of Clostridium difficile-Associated Diarrhea and Colitis: Usefulness of Premier Cytoclone A+B Enzyme Immunoassay for Combined Detection of Stool Toxins and Toxigenic C. difficileStrains

ABSTRACT Detection of Clostridium difficile toxins A and B in stools by Premier Cytoclone A+B enzyme immunoassay (EIA) was compared with detection by stool culture for C. difficile followed by detection of toxigenic isolates using the same EIA. Chart reviews were performed to evaluate the likelihood of C. difficile-associated diarrhea and colitis (CADC) for all patients with at least one positive toxin assay. While the toxins were detected in 58 of 85 consecutive CADC patients by both assays, CADC in 5 patients was detected only by stool toxin assay, and in 22 patients CADC was detected only by toxigenic culture. Our results suggest that for laboratories using a rapid toxin A+B EIA, direct toxin detection in stools should be combined with toxigenic culture in cases in which there is a negative stool toxin assay.

[1]  A. Limaye,et al.  Pseudomembranous Colitis Caused by a Toxin A− B+ Strain of Clostridium difficile , 2000, Journal of Clinical Microbiology.

[2]  Albert Balows,et al.  Manual of Clinical Microbiology, 7th ed. , 2000 .

[3]  D. Fedorko,et al.  Evaluation of Two Rapid Assays for Detection ofClostridium difficile Toxin A in Stool Specimens , 1999, Journal of Clinical Microbiology.

[4]  M. Alfa,et al.  An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. , 1999, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[5]  A. Jawad,et al.  Single toxin detection is inadequate to diagnose Clostridium difficile diarrhea in pediatric patients. , 1998, Gastroenterology.

[6]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Brazier.  The diagnosis of Clostridium difficile-associated disease. , 1998, The Journal of antimicrobial chemotherapy.

[8]  M. Campa,et al.  Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. , 1998, The Journal of antimicrobial chemotherapy.

[9]  J. Silva,et al.  Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C. difficile-associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  R. Schwalbe,et al.  Multicenter Evaluation of the Clostridium difficileTOX A/B TEST , 1998, Journal of Clinical Microbiology.

[11]  M. Delmée,et al.  Clostridium difficile toxin A detection on colonies. , 1997, Clinical Microbiology and Infection.

[12]  M. Delmée,et al.  Toxin A detection on Clostridium difficile colonies from 24-h cultures. , 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  L. Peterson,et al.  Clostridium Difficile-Associated Diarrhea and Colitis , 1995, Infection Control & Hospital Epidemiology.

[14]  T. Riley,et al.  Evaluation of three commercial enzyme immunoassay kits for detecting faecal Clostridium difficile toxins. , 1994, Journal of clinical pathology.

[15]  Kelly Mills,et al.  Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens , 1994, Journal of clinical microbiology.

[16]  J. Brazier.  Role of the laboratory in investigations of Clostridium difficile diarrhea. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  L. Peterson,et al.  The role of the clinical microbiology laboratory in the management of Clostridium difficile-associated diarrhea. , 1993, Infectious disease clinics of North America.

[18]  F. Barbut,et al.  Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea , 1993, Journal of clinical microbiology.

[19]  G. Doern,et al.  Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays , 1992, Journal of Clinical Microbiology.

[20]  L. Peterson,et al.  Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. , 1986, Archives of internal medicine.